copper sulfate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4282 7758-99-8

Description:

MoleculeDescription

Synonyms:

  • cupric sulfate
  • copper sulfate
  • copper sulfate pentahydrate
  • cupric sulfate pentahydrate
  • cupric sulfate anhydrous
A sulfate salt of copper. It is a potent emetic and is used as an antidote for poisoning by phosphorus. It also can be used to prevent the growth of algae.
  • Molecular weight: 159.60
  • Formula: CuO4S
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA:
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
May 5, 1987 FDA ABRAXIS PHARM

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC V03AB20 VARIOUS
ALL OTHER THERAPEUTIC PRODUCTS
ALL OTHER THERAPEUTIC PRODUCTS
Antidotes
CHEBI has role CHEBI:33287 fertilizers
CHEBI has role CHEBI:139492 sensitizers
CHEBI has role CHEBI:149552 emetics
MeSH PA D000931 Antidotes
MeSH PA D002491 Central Nervous System Agents
MeSH PA D004639 Emetics
MeSH PA D005765 Gastrointestinal Agents
MeSH PA D018373 Peripheral Nervous System Agents
MeSH PA D020011 Protective Agents

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Hypocupremia contraindication 19577007
Wilson's disease contraindication 88518009




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRouteExclusivity dateDescription
EQ 0.3MG COPPER/ML;EQ 55MCG BASE/ML;EQ 60MCG SELENIUM/ML;EQ 3MG BASE/ML (1ML) TRALEMENT AM REGENT N209376 July 2, 2020 RX SOLUTION INTRAVENOUS April 30, 2024 NEW CHEMICAL ENTITY
EQ 0.3MG COPPER/ML;EQ 55MCG BASE/ML;EQ 60MCG SELENIUM/ML;EQ 3MG BASE/ML (5ML) TRALEMENT AM REGENT N209376 Dec. 2, 2020 RX SOLUTION INTRAVENOUS April 30, 2024 NEW CHEMICAL ENTITY
EQ 60MCG COPPER/ML;EQ 3MCG BASE/ML;EQ 6MCG SELENIUM/ML;EQ 1000MCG BASE/ML (1ML) MULTRYS AM REGENT N209376 June 30, 2021 RX SOLUTION INTRAVENOUS April 30, 2024 NEW CHEMICAL ENTITY

Bioactivity Summary:

None

External reference:

IDSource
4020097 VUID
N0000148098 NUI
D03613 KEGG_DRUG
7758-98-7 SECONDARY_CAS_RN
4017628 VANDF
4017650 VANDF
4017708 VANDF
4020097 VANDF
C0056301 UMLSCUI
CHEBI:23414 CHEBI
CHEMBL604 ChEMBL_ID
D019327 MESH_DESCRIPTOR_UI
DB06778 DRUGBANK_ID
24462 PUBCHEM_CID
1999541 RXNORM
3686 MMSL
37539 MMSL
4503 MMSL
4513 MMSL
6110 MMSL
72601 MMSL
d04204 MMSL
000855 NDDF
001946 NDDF
007446 NDDF
423960007 SNOMEDCT_US
70168001 SNOMEDCT_US
LRX7AJ16DT UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Multitrace-4 Neonatal HUMAN PRESCRIPTION DRUG LABEL 4 0517-6202 INJECTION, SOLUTION 0.39 mg INTRAVENOUS UNAPPROVED DRUG OTHER 14 sections
Multitrace-5 HUMAN PRESCRIPTION DRUG LABEL 5 0517-8201 INJECTION, SOLUTION, CONCENTRATE 3.93 mg INTRAVENOUS UNAPPROVED DRUG OTHER 14 sections
Multitrace-5 HUMAN PRESCRIPTION DRUG LABEL 5 0517-8210 INJECTION, SOLUTION, CONCENTRATE 3.93 mg INTRAVENOUS UNAPPROVED DRUG OTHER 14 sections
Multitrace-5 HUMAN PRESCRIPTION DRUG LABEL 5 0517-8510 INJECTION, SOLUTION 1.57 mg INTRAVENOUS UNAPPROVED DRUG OTHER 14 sections
Multitrace -4 Pediatric HUMAN PRESCRIPTION DRUG LABEL 4 0517-9203 INJECTION, SOLUTION, CONCENTRATE 0.40 mg INTRAVENOUS UNAPPROVED DRUG OTHER 14 sections
Multrys HUMAN PRESCRIPTION DRUG LABEL 4 0517-9302 INJECTION, SOLUTION 150 ug INTRAVENOUS NDA 19 sections
Tralement HUMAN PRESCRIPTION DRUG LABEL 4 0517-9305 INJECTION, SOLUTION 0.30 mg INTRAVENOUS NDA 22 sections
Trace Elements 4 HUMAN PRESCRIPTION DRUG LABEL 4 0517-9310 INJECTION, SOLUTION 0.40 mg INTRAVENOUS UNAPPROVED DRUG OTHER 14 sections
Strovite One Caplets HUMAN PRESCRIPTION DRUG LABEL 20 0642-0207 TABLET 1.50 mg ORAL UNAPPROVED DRUG OTHER 14 sections
Se-Tan PLUS HUMAN PRESCRIPTION DRUG LABEL 13 13925-118 CAPSULE, GELATIN COATED 0.80 mg ORAL unapproved drug other 19 sections
Se-Tan PLUS HUMAN PRESCRIPTION DRUG LABEL 13 13925-118 CAPSULE, GELATIN COATED 0.80 mg ORAL unapproved drug other 19 sections
Quflora Pediatric Drops HUMAN PRESCRIPTION DRUG LABEL 13 15370-100 LIQUID 1 mg ORAL UNAPPROVED DRUG OTHER 11 sections
Quflora Pediatric Drops HUMAN PRESCRIPTION DRUG LABEL 13 15370-101 LIQUID 1 mg ORAL UNAPPROVED DRUG OTHER 11 sections
Quflora Pediatric HUMAN PRESCRIPTION DRUG LABEL 14 15370-103 TABLET, CHEWABLE 1 mg ORAL UNAPPROVED DRUG OTHER 12 sections
Quflora Pediatric HUMAN PRESCRIPTION DRUG LABEL 14 15370-104 TABLET, CHEWABLE 1 mg ORAL UNAPPROVED DRUG OTHER 12 sections
Quflora Pediatric HUMAN PRESCRIPTION DRUG LABEL 14 15370-105 TABLET, CHEWABLE 1 mg ORAL UNAPPROVED DRUG OTHER 12 sections
Centratex HUMAN PRESCRIPTION DRUG LABEL 13 23359-100 CAPSULE 0.80 mg ORAL unapproved drug other 13 sections
C-Nate DHA HUMAN PRESCRIPTION DRUG LABEL 13 23359-105 CAPSULE, GELATIN COATED 1 mg ORAL unapproved drug other 15 sections
Dynamiclear Rapid HUMAN OTC DRUG LABEL 3 49836-033 LIQUID 40 mg TOPICAL EXPORT ONLY 15 sections
Dynamiclear Rapid HUMAN OTC DRUG LABEL 3 49836-034 LIQUID 40 mg TOPICAL EXPORT ONLY 15 sections
Concept OB HUMAN PRESCRIPTION DRUG LABEL 15 52747-620 CAPSULE 800 ug ORAL unapproved drug other 13 sections
Concept DHA HUMAN PRESCRIPTION DRUG LABEL 15 52747-621 CAPSULE, LIQUID FILLED 2 mg ORAL unapproved drug other 7 sections
PureVit DualFe Plus HUMAN PRESCRIPTION DRUG LABEL 13 59088-112 CAPSULE 0.80 mg ORAL unapproved drug other 12 sections
Viva CT Prenatal HUMAN PRESCRIPTION DRUG LABEL 12 64661-811 TABLET, CHEWABLE 1 mg ORAL UNAPPROVED DRUG OTHER 16 sections
TRICARE PRENATAL HUMAN PRESCRIPTION DRUG LABEL 13 67112-101 TABLET, COATED 2 mg ORAL unapproved drug other 12 sections
TRICARE PRENATAL HUMAN PRESCRIPTION DRUG LABEL 13 67112-101 TABLET, COATED 2 mg ORAL unapproved drug other 12 sections
TRICARE PRENATAL DHA ONE HUMAN PRESCRIPTION DRUG LABEL 17 67112-401 CAPSULE, GELATIN COATED 2 mg ORAL unapproved drug other 12 sections
AQUATEC ALONGLIFE HUMAN OTC DRUG LABEL 1 80224-1000 SOLUTION 0.03 mg TOPICAL OTC monograph not final 10 sections
NANO - Q1 HUMAN OTC DRUG LABEL 1 80224-2000 SOLUTION 0.03 mg TOPICAL OTC monograph not final 10 sections